tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Immutep Ltd (PRRUF)
:PRRUF
US Market
PRRUF
Immutep Ltd
Overview
Analyst Forecasts
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Immutep Ltd (PRRUF) Stock News & Sentiment

Compare
20 Followers
Immutep Ltd Highlights Immune System Innovations at Healthcare Conference
Premium
Company Announcements
Immutep Ltd Highlights Immune System Innovations at Healthcare Conference
9d ago
Immutep’s Efti Combination Therapy Achieves Success in Phase II Soft Tissue Sarcoma Trial
Premium
Company Announcements
Immutep’s Efti Combination Therapy Achieves Success in Phase II Soft Tissue Sarcoma Trial
16d ago
Immutep’s Promising Phase 1 INSIGHT-003 Results Drive Buy Rating
Premium
Ratings
Immutep’s Promising Phase 1 INSIGHT-003 Results Drive Buy Rating
22d ago
IMMP
Immutep’s Efti Combination Shows Promising Results in Lung Cancer Trial
Premium
Company Announcements
Immutep’s Efti Combination Shows Promising Results in Lung Cancer Trial
27d ago
Immutep’s Promising Phase 2b Results and Strong Financial Position Justify Buy Rating
Premium
Ratings
Immutep’s Promising Phase 2b Results and Strong Financial Position Justify Buy Rating
1M ago
IMMP
Immutep’s Efti Shows Promising Results in Head and Neck Cancer Trial
Premium
Company Announcements
Immutep’s Efti Shows Promising Results in Head and Neck Cancer Trial
1M ago
Immutep Advances Cancer Trials with Promising Developments
Premium
Company Announcements
Immutep Advances Cancer Trials with Promising Developments
1M ago
More PRRUF News >

PRRUF News on the Web

Immutep Ltd Highlights Immune System Innovations at Healthcare Conference
TipRanks News
Neutral
Health Check: The endo-metriosis? Proteomics is on the case
StockHead
Neutral
Up 34% since April, ASX 300 healthcare stock lifts off again today on new milestone
The Motley Fool
Neutral
Immutep’s Efti Combination Therapy Achieves Success in Phase II Soft Tissue Sarcoma Trial
TipRanks News
Neutral
High Growth Tech Stocks in Australia Featuring Life360 and Two Others
Simply Wall St
Neutral
Immutep delivers major breakthrough with 59.6% response rate in lung cancer trial
Small Caps AU
Neutral
Health Check: Amplia shares surge on pancreatic cancer trial results; Immutep offers hope
StockHead
Neutral
Closing Bell: Gold shines bright despite minor market dip
StockHead
Neutral

News Score - Last 7 Days

Neutral
PRRUF
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PRRUF’s Media Buzz Sentiment?
Currently, no data Available
What is PRRUF’s weekly average amount of articles?
Currently, no data Available
What is PRRUF’s News Sentiment?
59% of articles about PRRUF were positive this week, compared to its sector average of 55%.
    Healthcare Stocks that are Trending in the News
    THCTenet Healthcare
    HQYHealthequity
    ALNYAlnylam Pharma
    CPRXCatalyst Pharma
    SRPTSarepta Therapeutics
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing